Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin

Clinical trial NCT04999176 · UNKNOWN

Trial details

NCT number: NCT04999176
Sponsor: André Luiz Malavasi Longo de Oliveira
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Cancer Rivaroxaban Venous Thromboembolism Thromboprophylaxis

Start date: 2020-10-22
Primary completion: 2024-07-15
Enrollment: 440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.